← Leaderboards
Martha Kelly
Locus Pharmaceuticals, Inc.
$235,600
Attributed
$235,600
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$235,600 · 1
By mechanism
R43$235,600 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “17-(Dimethylaminoethylamino)-17-Demethoxygeldanamycin”
- David Ross · University Of Colorado Denver$1,912,680
- Pranoti Mandrekar · Univ Of Massachusetts Med Sch Worcester$1,909,027
- Kapil N. Bhalla · University Of Tx Md Anderson Can Ctr$1,531,833
- Duxin Sun · University Of Michigan At Ann Arbor$1,406,021
- Gabriela Chiosis · Sloan-Kettering Inst Can Research$1,014,709
- Ari M. Melnick · Mount Sinai School Of Medicine Of Nyu$1,014,709
Research focus
17-(Dimethylaminoethylamino)-17-DemethoxygeldanamycinAffinityAnalogAnsamycin Antineoplastic AntibioticAnti-Cancer TherapeuticAtp PhosphohydrolaseBaseBinding (Molecular Function)Binding SitesBioavailableBiologicalCancer CellCancer TherapyCellsChemotherapeutic AgentClassClientClinicCommercial ApplicationComputer SimulationCooperative Research And Development AgreementCrystallographyDesign17-(Allylamino)-17-Demethoxygeldanamycin